Saluda Medical, Inc. (ASX:SLD)
Australia · Delayed Price · Currency is AUD 0.4250
-0.0300 (-6.59%)
Last updated: Sep 2, 2026, 12:01 PM AEST
Saluda Medical Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Saluda Medical stock has a consensus rating of "Strong Buy" and an average price target of $2.13. The average 1-year stock price forecast is 401.18% higher than the current stock price, while the lowest is $1.55 (+264.71%) and the highest is $2.88 (+577.65%).
Price Target: $2.13 (+401.18%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Saluda Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 3 | 3 |
Financial Forecast
Revenue This Year
122.15M
from 90.18M
Increased by 35.46%
Revenue Next Year
184.09M
from 122.15M
Increased by 50.71%
EPS This Year
-0.37
EPS Next Year
-0.28
from -0.37
EPS and Forward PE are based on non-GAAP adjusted numbers.